Birdwatch Archive

Birdwatch Note

2023-05-30 02:49:28 UTC - NOT_MISLEADING

O servidor público lutava contra um linfoma quando buscou o Hospital das Clínicas de Rib. Preto (HCRP), apresentando um quadro terminal e aceitou participar do tratamento experimental de células CAR-T. Em menos de 30 dias, as células cancerígenas haviam reduzido drasticamente. https://butantan.gov.br/noticias/primeiro-brasileiro-a-receber-a-terapia-celular-car-t-apresentou-remissao-de-tumores-em-menos-de-um-mes

Written by F51B28F097DBE28E05837F92EC42D071406CAB2649BADBFA037C53CF4229EFB8
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1663315588230397955

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1663377052962045953
  • noteId - 1663377052962045953
  • participantId -
  • noteAuthorParticipantId - F51B28F097DBE28E05837F92EC42D071406CAB2649BADBFA037C53CF4229EFB8 Participant Details
  • createdAtMillis - 1685414968136
  • tweetId - 1663315588230397955
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 1
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • O servidor público lutava contra um linfoma quando buscou o Hospital das Clínicas de Rib. Preto (HCRP), apresentando um quadro terminal e aceitou participar do tratamento experimental de células CAR-T. Em menos de 30 dias, as células cancerígenas haviam reduzido drasticamente. https://butantan.gov.br/noticias/primeiro-brasileiro-a-receber-a-terapia-celular-car-t-apresentou-remissao-de-tumores-em-menos-de-um-mes

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-05-30 02:49:28 UTC
(1685414968136)
1969-12-31 23:59:59 UTC
(-1)
2023-05-31 02:39:52 UTC
(1685500792003)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-30 16:24:02 -0500 Rating Details
2023-05-30 15:45:28 -0500 Rating Details
2023-05-30 15:38:10 -0500 Rating Details
2023-05-30 14:27:06 -0500 Rating Details
2023-05-30 12:02:47 -0500 Rating Details
2023-05-30 10:59:11 -0500 Rating Details
2023-05-30 10:50:09 -0500 Rating Details
2023-05-30 10:15:04 -0500 Rating Details
2023-05-30 09:40:06 -0500 Rating Details
2023-05-30 09:28:56 -0500 Rating Details
2023-05-30 07:43:56 -0500 Rating Details
2023-05-30 07:20:52 -0500 Rating Details
2023-05-30 07:12:01 -0500 Rating Details
2023-05-30 06:00:32 -0500 Rating Details
2023-05-30 05:53:46 -0500 Rating Details
2023-05-30 04:50:06 -0500 Rating Details
2023-05-30 04:33:38 -0500 Rating Details
2023-05-30 04:32:59 -0500 Rating Details
2023-05-30 03:31:22 -0500 Rating Details
2023-05-29 23:26:46 -0500 Rating Details
2023-05-29 22:17:38 -0500 Rating Details
2023-05-29 21:53:41 -0500 Rating Details
2023-05-29 21:50:45 -0500 Rating Details